This work aims the synthesis of amidino pyrazolines by the cyclocondensation reaction between 3-(hetero)aryl-1-(2-hydroxyphenyl)enones and aminoguanidine hydrochloride under sonochemical conditions. Thirteen new compounds were synthesized in 15-83% of yield after sonication for 30 min without purification by chromatography. Furthermore, antimicrobial activities of the synthesized compounds were investigated by in vitro minimum inhibitory concentration (MIC) in a panel of four bacterial strains and four Candida yeasts. As result, the 5-(4-bromophenyl)-3-(2-hydroxyphenyl)-4,5-dihydro-1H-pyrazole-1-carboximidamide hydrochloride was identified as the most active against gram-positive S. aureus and E. faecalis with MIC of 7.8 µg mL −1 , similar to the value showed by chloramphenicol, which was used as standard.
Introduction
Pyrazoles and their non-aromatic analogous pyrazolines are important scaffolds for the development of new biologically active compounds. 1 Although pyrazolecontaining natural products are rare, many synthetic molecules bearing this heterocycle are clinically approved pharmaceuticals such as celecoxib (anti-inflammatory activity), 2 sildenafil (treatment of erectile dysfunction), 3 and rimonabant (treatment of obesity), 4 as well as agrochemicals such as chlorantraniliprole (insecticide), 5 fipronil (insecticide), 6 and pyraclostrobin (fungicide). 7 The related pyrazolines are motifs commonly found in compounds with potent bioactivities such as antibacterial, 8 antifungal, 9 antiviral, 10 anti-inflamatory, 11 antioxidant, 12 anticancer, 13 antidepressant and antianxiety. 14 In the same context, amidine-containing compounds show recognized bioactivities. Pentamidine is included on the World Health Organization's List of Essential Medicines for the basic health system indicated for the treatment of first stage human African tripanosomiasis and as a second-line therapy for leishmaniasis. 15 In this concern, amidine-containing molecules have been pointed as prominent prototypes in the search for new antimicrobial agents. 16 In the last years, the ultrasonic irradiation as green energy source has been applied in the field of pharmaceutical and green chemistry. The beneficial effect of sonication on organic synthesis are attributed to cavitation which creates special local conditions in the reaction medium. As result, reactions have been completed in shorter reaction times and products have been obtained in higher yields than under conventional methods. 17 Recently, we demonstrated that ultrasonic irradiation was valuable in promoting the cyclocondensation reaction of chalcones and aminoguanidine hydrochloride for the synthesis of amidino pyrazolines. 18 This method prompted us to synthesize series of pyrazolines in short reaction times and good yields using ethanol as green solvent despite the low solubility of aminoguanidine in such medium.
In continuation to this program, in this work we sought to promote the cyclocondensation reaction of phenolic chalcones and aminoguanidine hydrochloride under ultrasonic irradiation, aiming the synthesis of water soluble phenolic amidino pyrazolines hydrochlorides. Furthermore, searching for antimicrobial compounds, all new products were tested against gram-positive and gram-negative bacteria and Candida type yeasts.
Experimental

General
All the chemicals were used without purification as purchased from commercial suppliers (Sigma-Aldrich, St. Louis, USA). The sonicated reactions were carried out with a microtip probe connected to a 500 W Sonics Vibracell ultrasonic processor operating at 20 kHz at 20% of the maximum power output. Melting point values were determined in open capillary on an Instrutherm DF-3600 II apparatus and are uncorrected. Infrared spectra (FTIR) were acquired on a JASCO-4100 spectrophotometer. 1 H and 13 C nuclear magnetic resonance (NMR) spectra were acquired on a Bruker Avance III HD instrument (300 MHz for 1 H and 75 MHz for 13 C) in 5 mm sample tubes at 298 K in dimethyl sulfoxide (DMSO-d 6 ). A hybrid highresolution and high accuracy microTof (Q-TOF) (Bruker ® Scientific) was used for detection, with electrospray ionization (ESI) source (MicrOTOF-QII Bruker ® Scientific) in positive mode. The compounds 3a-3m were dissolved individually in a solution of 50% (v/v) chromatographic grade acetonitrile (Tedia, Fairfield, OH, USA), 50% (v/v) deionized water and 0.1% formic acid. The solutions were infused directly into the ESI source by means of a syringe pump (Harvard Apparatus) at a flow rate of 180 µL min −1 . The drying temperature was 200 ºC and nitrogen was used for drying gas, in a 10 L min −1 flow. The ESI(+)-MS and tandem ESI(+)-MS/MS were acquired under the following conditions: capillary and cone voltages were set to +3500 V and +40 V, respectively, with a desolvation temperature of 100 ºC. For ESI(+)-MS/MS, the energy for the collision induced dissociations (CID) was optimized for each component. The software Compass DataAnalysis version 4.3 (Bruker ® Scientific) was used for spectrum analysis. The diagnostic ions were identified by the comparison of their ESI(+)-MS/MS dissociation patterns with compounds with theoretical mass for the respective elementary formula. The data were collected in the m/z range of 70-2000 at the speed of two scans per second, providing the resolution of 50,000 (full width at half maximum, FWHM) at m/z 200. No important ions were observed below m/z 100 or above m/z 700, therefore ESI(+)-MS data is shown in the m/z 100-700 range. Diffraction data were collected on a Bruker D8 Venture Photon 100 diffractometer equipped with an Incoatec IµS high brilliance Mo-Kα X ray tube with twodimensional Montel micro-focusing optics. The structure was solved by direct methods using SHELXS. 19 Subsequent Fourier-difference map analyses yielded the positions of the non-hydrogen atoms. Refinements were carried out with the SHELXL package. 19 All refinements were made by fullmatrix least-squares on F2 with anisotropic displacement parameters for all non-hydrogen atoms. Hydrogen atoms were included in the refinement in calculated positions but the atoms (of hydrogens) that are commenting performing special bond were located in the Fourier map. Drawings were done using ORTEP-31 for Windows 20 crystal data and more details of the data collection and refinements of the compound 3a is presented in Table 1 .
Chemistry
Procedure for the synthesis of 4,5-dihydro-1H-pyrazole-1-carboximidamides 3a-m A mixture of 3-(hetero)aryl-1-(2-hydroxyphenyl) enone 1a-1m (1.0 mmol), aminoguanidine hydrochloride 2 (0.22 g, 2.0 mmol) and potassium hydroxide (0.11 g, 2.0 mmol) in ethanol (15 mL) was sonicated for 30 min. After the excess of aminoguanidine hydrochloride had been filtered off, the resulting solution was quenched with 10% hydrogen chloride (15 mL). The mixture was extracted with chloroform (3 × 30 mL) and the combined organic layer was dried over MgSO 4 . The solvent was evaporated and the residue was purified by recrystallization from ethyl acetate-methanol (10:1) to afford the 4,5-dihydro-1H-pyrazole-1-carboximidamides 3a-3l as crystalline solids. For the extraction of 3m, after removal of excess of aminoguanidine, the filtrate was treated with a saturated solution of NaCl and extracted with chloroform (3 × 30 mL). The combined organic layer was acidified with some drops of concentrated hydrogen chloride, dried over MgSO 4 
Results and Discussion
Synthesis and structural characterization 3-(Hetero)aryl-1-(2-hydroxyphenyl)enones 1a-1m were prepared according to previously reported procedures. 22 Sonication of 1a-1m and aminoguanidine hydrochloride 2 for 30 min in the presence of potassium hydroxide using ethanol as solvent, and further treatment with 10% hydrogen chloride before extraction, afforded the novel 4,5-dihydro-1H-pyrazole-1-carboximidamides hydrochlorides 3a-3m in acceptable to good yields (15-83%) (Scheme 1). The method determined here showed some advantages including the short reaction time, non-chromatographic purification and hydroxyl protection/deprotection steps not required. Unfortunately, all the new compounds were water-insoluble. Consequently, dimethyl sulfoxide was used as the solvent for the bactericidal and fungicidal tests.
The mechanism of the cyclocondensation reaction between aminoguanidine and α,β-unsaturated ketones for synthesis of amidino pyrazolines remains experimentally unestablished. However, we propose the mechanism showed in Scheme 2 based on a previously reported mechanism 23 that considered the hard and soft acids and bases (HSAB) concept and the structure of aminoguanidine obtained by quantum chemical studies. 24 In the first step, the KOH neutralizes the aminoguanidine salt 2 to give aminoguanidine free base (tautomer forms). In the same line, the phenol is deprotonated by the KOH leading to the formation of the phenoxide intermediate I. In the next step, the Aza-Michael-type addition with the internal imine nitrogen gives the intermediate II. Subsequently, III is formed after an intramolecular nucleophilic attack by nitrogen, which is dehydrated to give the product IV. The product 3 is formed after the reaction media is acidified.
The structure elucidation of compounds 3a-3m was performed from analysis of their spectroscopic and spectrometric data (FTIR, 1 H NMR, 13 In the same line, the fit of isotopic ratio (theoretical versus experimental) assist in the confirmation of elementary composition of synthesized compounds, being in the 3d example equal to 23.6 msig. Errors of exact m/z below 10 ppm, as well as differences of isotopic ratios less than 25 msig, for HRMS with ionization by ESI and mass separation by quadrupole-time of flight (Q-TOF), confirm the elemental composition. 25 Moreover, the fragmentation pathway has important information about the molecular structure. For the title compounds, it is similar to that proposed by Kéki et al., 26 for 1,3,5-trisubstituted pyrazolines, as well as dos Santos et al. 27 for dihydropyrimidines. The Figure 1 demonstrates this HRMS tools used to characterize the synthesized amidino pyrazolines, using as example the compound 3d. For the other compounds, see the Supplementary Information (SI) section.
Finally, the molecular structure of compound 3a was confirmed by single X-ray diffraction analysis (Figure 2 ). It shows a protonated amidino-nitrogen atom resulting in a delocalized positive charge in the N3−C4−N4 system, according to the symmetric bond length between N3−C4 = 1.325(4) Å and C4−N4 = 1.323(4) Å. These values are intermediate between single and double C-N bond lengths and are very close to those reported for the protonated amidino group in the aminoguanidine hydrochloride structure. 28 The electroneutrality is achieved by a chloride anion. Additionally, an ethanol molecule is observed as a solvate. Crystal data, data collection and structure refinement details are summarized in Table 1 . Other crystallographic data for 3a are shown in the SI section.
The one-dimensional (1-D) growth of 3a in the bc plane is represented in Figure 3 
Antibacterial activity
All the novel compounds were screened for their in vitro antibacterial activity against gram-positive and gram-negative bacteria. The minimum inhibitory concentrations (MIC) were determined and reported in Table 2 . Gram-negative bacteria E. coli and S. Enteritidis can be found in the gastrointestinal tract of humans and other animals, causing diarrhea and other systemic diseases. 30 Gram-positive bacteria constitute important clinical risk and are responsible for high mortality rates associated with bloodstream infections. In addition, methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus spp. resistant to vancomycin (VRE) show the importance of the development of new antibiotics. 31 In this concern, compounds 3a-3f,3k showed selectivity for gram-positive bacteria Staphylococcus aureus and Enterococcus faecalis with MIC values in the range 31.2-62.5 µg mL −1 . On the other hand, compound 3j was active against the four tested strains (MIC 31.2 µg mL −1 ). Compound 3h also showed discrete inhibition against both gram-positive and gram-negative bacteria. Compound 3i was the most active, showing inhibitory activity against Staphylococcus aureus (MIC 7.8 µg mL −1 ) and Enterococcus faecalis (MIC 7.8 µg mL −1 ). These MIC values are lower than those observed for the licensed antibiotic chloramphenicol against S. aureus and E. faecalis. This compound also showed moderate inhibition against Salmonella enteritidis (MIC 62.5 µg mL −1 ) and Escherichia coli (MIC 62.5 µg mL −1 ). These data show that bromine at 4-position of the benzene ring is essential for molecule activity. When this atom is shifted to 3-position there is an 8-fold decrease in compound activity against S. aureus and E. faecalis strains. Additionally, the change of bromine by a fluorine atom attached at 4-position produced a molecule 16-fold less active against S. aureus and E. faecalis. Electron donating groups at 4-position, like methyl and methoxyl, cause at least a 4-fold decrease in compound activity against S. aureus and E. faecalis.
These results indicate that compounds 3h-3j may be used as prototype for new broad-spectrum antibiotics.
Antifungal activity
The MIC against four Candida type yeasts were determined and reported in Table 3 . These Candida species were chosen because they are important opportunistic pathogens besides provide infections due to their virulence factors and resistance to antifungal agents. 32 Most of amidino pyrazolines did not show high antifungal activity. Only 3c and 3i moderately inhibited the growth of C. krusei and C. tropicalis. Compound 3k also showed moderate activity against C. tropicalis.
Conclusions
In summary, a concise and greener method for the synthesis of amidino pyrazolines under sonochemical conditions was achieved. The 13 new compounds were obtained in moderate to good yields without additional purification. The structural characterization was unequivocal using FTIR, 1 H and 13 C NMR, HRMS and X-ray diffraction. Concerning the antimicrobial tests, some pyrazolines exhibited promising in vitro antibacterial activity. In this sense, the compound 3i (Ar = 4-BrC 6 H 4 ) presented the most promising values of MIC, which was comparable with the standard antibiotic chloramphenicol against S. aureus and E. faecalis. In this line, future studies can highlight these amidino pyrazoline as drugs prototypes. Amphotericin B − 0.25 0.06 0.06 0.06 MIC: minimum inhibitory concentration.
